Omniscan (Gadodiamide)

Gadodiamide, the active ingredient in Omniscan, is a gadolinium‑based contrast agent presented as a solution for intravenous use. It enhances magnetic resonance imaging to help visualize vascular structures and tissue characteristics in patients undergoing diagnostic procedures. GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and imaging centres worldwide.

GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and imaging centres worldwide.

Omniscan is a gadolinium‑based contrast agent used in magnetic resonance imaging to improve visualization of several body systems.

- Central nervous system imaging: Enhances detection of lesions, tumors, and vascular abnormalities. - Cardiovascular imaging: Improves delineation of cardiac chambers, vessels, and myocardial perfusion. - Abdominal and pelvic imaging: Aids in characterizing lesions in liver, kidneys, and other abdominal organs.

Adverse reactions to Omniscan are generally mild but can vary in severity.

Common Side Effects: - Nausea - Headache - Warmth or flushing sensation - Mild itching or rash - Transient dizziness - Elevated blood pressure

Serious or Rare Side Effects: - Nephrogenic systemic fibrosis (NSF) in patients with severe renal impairment - Severe allergic reactions including anaphylaxis - Acute kidney injury - Cardiac arrhythmias - Pulmonary edema - Persistent severe headache or neurological changes

When using Omniscan, several precautions should be observed to ensure patient safety.

- Renal function assessment: Evaluate the patient before administration. - Hydration status: Ensure adequate hydration before and after the procedure. - Prior contrast reactions: Review history of previous contrast‑related adverse events. - Pregnancy :     t  t      \

{"???":"???"}